DiaSorin S.p.A. (OTCMKTS:DSRLF) Sees Significant Growth in Short Interest

DiaSorin S.p.A. (OTCMKTS:DSRLF) saw a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 218,900 shares, a growth of 58.9% from the February 13th total of 137,800 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 2,189.0 days. Approximately 0.4% of the company’s shares are sold short.

DiaSorin Price Performance

DiaSorin stock remained flat at $109.60 during trading on Friday. The company has a 50 day moving average price of $104.96 and a two-hundred day moving average price of $104.08. DiaSorin has a 1-year low of $100.26 and a 1-year high of $109.60.

Analyst Ratings Changes

Separately, UBS Group downgraded DiaSorin from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 26th.

DiaSorin Company Profile

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.